Short-term and long-term outcomes of liver resection for HCC patients with portal vein tumor thrombus

被引:21
作者
Huo, Lei [1 ,2 ]
Wei, Wenxin [1 ]
Yan, Zhenlin [1 ]
Lei, Zhengqing [1 ,3 ]
Xie, Yanting [1 ]
Gong, Renyan [1 ]
Huang, Shengyu [1 ]
Jia, Ningyang [2 ]
Xia, Yong [1 ]
机构
[1] Second Mil Med Univ, Eastern Hepatobiliary Surg Hosp, Dept Hepat Surg 4, 225 Changhai Rd, Shanghai 200433, Peoples R China
[2] Second Mil Med Univ, Eastern Hepatobiliary Surg Hosp, Dept Radiotherapy, Shanghai 200438, Peoples R China
[3] Southeast Univ, Zhongda Hosp, Dept Gen Surg, Nanjing 210009, Jiangsu, Peoples R China
关键词
Hepatocellular carcinoma; Portal vein tumor thrombosis; Hepatectomy; Prognosis; HEPATOCELLULAR-CARCINOMA; TRANSARTERIAL CHEMOEMBOLIZATION; CONSENSUS RECOMMENDATIONS; SURVIVAL;
D O I
10.1186/s13578-019-0285-z
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
BackgroundPortal vein tumor thrombosis (PVTT) in hepatocellular carcinoma (HCC) is a sign of advanced stage disease, which is associated with poor prognosis. Liver resection (LR) may provide better prognosis in selected patients. In the present study, we aimed to assess information from HCC patients with PVTT who died within 3months or 2years after LR in order to identify preoperative factors correlated to short-term or long-term survival, by which inappropriate selection of patients for LR might be avoided in the future.MethodsA retrospective cohort study consisting of 487 consecutive cases of HCC patients with PVTT was performed from 2008 to 2010 at Eastern Hepatobiliary Surgery Hospital. Medical records, including laboratory values, imaging results and treatment information, were obtained from participants. Study endpoints were survival at 3months and 2years post-hepatectomy. Logistic regression analysis was utilized to determine the significant pre-operative factors influencing short-term or long-term survival.ResultsIn multivariable analysis, -fetoprotein, total bilirubin and radiologic ascites were significantly associated with short-term survival, while -fetoprotein level, clinical significant portal hypertension, extent of PVTT and tumor differentiation were factors significantly associated with long-term survival.ConclusionsThe independent risk factors of poor short-term survival were the liver function-associated, such as factors radiologic ascites and total bilirubin, while tumor differentiation indicating the tumor biology was associated with longer-term survival. In addition, -fetoprotein was a risk factor associated with both short-term and longer-term survivals.
引用
收藏
页数:12
相关论文
共 19 条
[1]   Portal Hypertension and the Outcome of Surgery for Hepatocellular Carcinoma in Compensated Cirrhosis: A Systematic Review and Meta-analysis [J].
Berzigotti, Annalisa ;
Reig, Maria ;
Abraldes, Juan G. ;
Bosch, Jaime ;
Bruix, Jordi .
HEPATOLOGY, 2015, 61 (02) :526-536
[2]   Hepatocellular carcinoma: clinical frontiers and perspectives [J].
Bruix, Jordi ;
Gores, Gregory J. ;
Mazzaferro, Vincenzo .
GUT, 2014, 63 (05) :844-855
[3]   Management of Hepatocellular Carcinoma: An Update [J].
Bruix, Jordi ;
Sherman, Morris .
HEPATOLOGY, 2011, 53 (03) :1020-1022
[4]   Effects of location and extension of portal vein tumor thrombus on long-term outcomes of surgical treatment for hepatocellular carcinoma [J].
Chen, XP ;
Qiu, FZ ;
Wu, ZD ;
Zhang, ZW ;
Huang, ZY ;
Chen, YF ;
Zhang, BX ;
He, SQ ;
Zhang, WG .
ANNALS OF SURGICAL ONCOLOGY, 2006, 13 (07) :940-946
[5]   Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial [J].
Cheng, Ann-Lii ;
Kang, Yoon-Koo ;
Chen, Zhendong ;
Tsao, Chao-Jung ;
Qin, Shukui ;
Kim, Jun Suk ;
Luo, Rongcheng ;
Feng, Jifeng ;
Ye, Shenglong ;
Yang, Tsai-Sheng ;
Xu, Jianming ;
Sun, Yan ;
Liang, Houjie ;
Liu, Jiwei ;
Wang, Jiejun ;
Tak, Won Young ;
Pan, Hongming ;
Burock, Karin ;
Zou, Jessie ;
Voliotis, Dimitris ;
Guan, Zhongzhen .
LANCET ONCOLOGY, 2009, 10 (01) :25-34
[6]   Hepatocellular carcinoma [J].
Forner, Alejandro ;
Reig, Maria ;
Bruix, Jordi .
LANCET, 2018, 391 (10127) :1301-1314
[7]   Is there any difference in survival according to the portal tumor thrombectomy method in patients with hepatocellular carcinoma? [J].
Inoue, Yosuke ;
Hasegawa, Kiyoshi ;
Ishizawa, Takeaki ;
Aoki, Taku ;
Sano, Keiji ;
Beck, Yoshifumi ;
Imamura, Hiroshi ;
Sugawara, Yasuhiko ;
Kokudo, Norihiro ;
Makuuchi, Masatoshi .
SURGERY, 2009, 145 (01) :9-19
[8]   Evidence-based Clinical Practice Guidelines for Hepatocellular Carcinoma: The Japan Society of Hepatology 2013 update (3rd JS']JSH-HCC Guidelines) [J].
Kokudo, Norihiro ;
Hasegawa, Kiyoshi ;
Akahane, Masaaki ;
Igaki, Hiroshi ;
Izumi, Namiki ;
Ichida, Takafumi ;
Uemoto, Shinji ;
Kaneko, Shuichi ;
Kawasaki, Seiji ;
Ku, Yonson ;
Kudo, Masatoshi ;
Kubo, Shoji ;
Takayama, Tadatoshi ;
Tateishi, Ryosuke ;
Fukuda, Takashi ;
Matsui, Osamu ;
Matsuyama, Yutaka ;
Murakami, Takamichi ;
Arii, Shigeki ;
Okazaki, Masatoshi ;
Makuuchi, Masatoshi .
HEPATOLOGY RESEARCH, 2015, 45 (02) :123-127
[9]   Survival outcomes of hepatic resection compared with transarterial chemoembolization or sorafenib for hepatocellular carcinoma with portal vein tumor thrombosis [J].
Lee, Jung Min ;
Jang, Byoung Kuk ;
Lee, Yoo Jin ;
Choi, Wang Yong ;
Choi, Sei Myong ;
Chung, Woo Jin ;
Hwang, Jae Seok ;
Kang, Koo Jeong ;
Kim, Young Hwan ;
Chauhan, Anil Kumar ;
Park, Soo Young ;
Tak, Won Young ;
Kweon, Young Oh ;
Kim, Byung Seok ;
Lee, Chang Hyeong .
CLINICAL AND MOLECULAR HEPATOLOGY, 2016, 22 (01) :160-167
[10]   Surgical Resection Versus Transarterial Chemoembolization for Hepatocellular Carcinoma with Portal Vein Tumor Thrombosis: A Propensity Score Analysis [J].
Liu, Po-Hong ;
Lee, Yun-Hsuan ;
Hsia, Cheng-Yuan ;
Hsu, Chia-Yang ;
Huang, Yi-Hsiang ;
Chiou, Yi-You ;
Lin, Han-Chieh ;
Huo, Teh-Ia .
ANNALS OF SURGICAL ONCOLOGY, 2014, 21 (06) :1825-1833